• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR-Cas9 胞嘧啶和腺嘌呤碱基编辑剪接位点可介导在原代和永生化细胞中高效破坏蛋白质。

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells.

机构信息

Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.

Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.

出版信息

Nat Commun. 2021 Apr 23;12(1):2437. doi: 10.1038/s41467-021-22009-2.

DOI:10.1038/s41467-021-22009-2
PMID:33893286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8065034/
Abstract

CRISPR-Cas9 cytidine and adenosine base editors (CBEs and ABEs) can disrupt genes without introducing double-stranded breaks by inactivating splice sites (BE-splice) or by introducing premature stop (pmSTOP) codons. However, no in-depth comparison of these methods or a modular tool for designing BE-splice sgRNAs exists. To address these needs, we develop SpliceR ( http://z.umn.edu/spliceR ) to design and rank BE-splice sgRNAs for any Ensembl annotated genome, and compared disruption approaches in T cells using a screen against the TCR-CD3 MHC Class I immune synapse. Among the targeted genes, we find that targeting splice-donors is the most reliable disruption method, followed by targeting splice-acceptors, and introducing pmSTOPs. Further, the CBE BE4 is more effective for disruption than the ABE ABE7.10, however this disparity is eliminated by employing ABE8e. Collectively, we demonstrate a robust method for gene disruption, accompanied by a modular design tool that is of use to basic and translational researchers alike.

摘要

CRISPR-Cas9 胞嘧啶和腺嘌呤碱基编辑器(CBEs 和 ABEs)可以通过失活剪接位点(BE-splice)或引入过早终止(pmSTOP)密码子来破坏基因,而无需引入双链断裂。然而,目前还没有对这些方法进行深入比较,也没有用于设计 BE-splice sgRNA 的模块化工具。为了解决这些需求,我们开发了 SpliceR(http://z.umn.edu/spliceR),用于设计和对任何 Ensembl 注释基因组进行排名 BE-splice sgRNA,并在针对 TCR-CD3 MHC 类 I 免疫突触的筛选中比较 T 细胞中的破坏方法。在靶向基因中,我们发现靶向剪接供体是最可靠的破坏方法,其次是靶向剪接受体,然后是引入 pmSTOP。此外,CBE BE4 比 ABE ABE7.10 更有效,但通过使用 ABE8e 可以消除这种差异。总的来说,我们展示了一种强大的基因破坏方法,同时还提供了一个模块化的设计工具,这对基础和转化研究人员都很有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/2758dfcc25a2/41467_2021_22009_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/e345fe1ffe4f/41467_2021_22009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/6f7c24b21956/41467_2021_22009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/9e49d3d51ac6/41467_2021_22009_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/46b61bbc0250/41467_2021_22009_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/e4a4e72e96a4/41467_2021_22009_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/60c3750e9a18/41467_2021_22009_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/2758dfcc25a2/41467_2021_22009_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/e345fe1ffe4f/41467_2021_22009_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/6f7c24b21956/41467_2021_22009_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/9e49d3d51ac6/41467_2021_22009_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/46b61bbc0250/41467_2021_22009_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/e4a4e72e96a4/41467_2021_22009_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/60c3750e9a18/41467_2021_22009_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c720/8065034/2758dfcc25a2/41467_2021_22009_Fig7_HTML.jpg

相似文献

1
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells.CRISPR-Cas9 胞嘧啶和腺嘌呤碱基编辑剪接位点可介导在原代和永生化细胞中高效破坏蛋白质。
Nat Commun. 2021 Apr 23;12(1):2437. doi: 10.1038/s41467-021-22009-2.
2
Highly efficient RNA-guided base editing in rabbit.高效的兔 RNA 引导碱基编辑。
Nat Commun. 2018 Jul 13;9(1):2717. doi: 10.1038/s41467-018-05232-2.
3
Efficient base editing by RNA-guided cytidine base editors (CBEs) in pigs.通过 RNA 引导的胞嘧啶碱基编辑器(CBEs)在猪中进行高效的碱基编辑。
Cell Mol Life Sci. 2020 Feb;77(4):719-733. doi: 10.1007/s00018-019-03205-2. Epub 2019 Jul 13.
4
CRISPR-CBEI: a Designing and Analyzing Tool Kit for Cytosine Base Editor-Mediated Gene Inactivation.CRISPR-CBEI:一种用于胞嘧啶碱基编辑器介导的基因失活的设计与分析工具包。
mSystems. 2020 Sep 22;5(5):e00350-20. doi: 10.1128/mSystems.00350-20.
5
In Vivo Rapid Investigation of CRISPR-Based Base Editing Components in (IRI-CCE): A Platform for Evaluating Base Editing Tools and Their Components.体内快速研究基于 CRISPR 的碱基编辑组件在 (IRI-CCE):一个用于评估碱基编辑工具及其组件的平台。
Int J Mol Sci. 2022 Jan 20;23(3):1145. doi: 10.3390/ijms23031145.
6
Multiplex Gene Disruption by Targeted Base Editing of Yarrowia lipolytica Genome Using Cytidine Deaminase Combined with the CRISPR/Cas9 System.利用胞嘧啶脱氨酶与 CRISPR/Cas9 系统靶向编辑解脂耶氏酵母基因组实现多基因敲除。
Biotechnol J. 2020 Jan;15(1):e1900238. doi: 10.1002/biot.201900238. Epub 2019 Nov 11.
7
Exploring C-to-G and A-to-Y Base Editing in Rice by Using New Vector Tools.利用新型载体工具探索水稻中的 C 到 G 和 A 到 Y 碱基编辑。
Int J Mol Sci. 2022 Jul 20;23(14):7990. doi: 10.3390/ijms23147990.
8
A Cas9-mediated adenosine transient reporter enables enrichment of ABE-targeted cells.CRISPR/Cas9 介导的腺苷瞬时报告基因可用于富集 ABE 靶向细胞。
BMC Biol. 2020 Dec 14;18(1):193. doi: 10.1186/s12915-020-00929-7.
9
Base Editing in Poplar Through an Agrobacterium-Mediated Transformation Method.通过农杆菌介导转化法在杨树中进行碱基编辑
Methods Mol Biol. 2023;2653:53-71. doi: 10.1007/978-1-0716-3131-7_4.
10
Base editing in rice: current progress, advances, limitations, and future perspectives.碱基编辑在水稻中的应用:当前进展、进展、局限性和未来展望。
Plant Cell Rep. 2021 Apr;40(4):595-604. doi: 10.1007/s00299-020-02656-3. Epub 2021 Jan 10.

引用本文的文献

1
Species-specific serine metabolism differentially controls natural killer cell functions.物种特异性丝氨酸代谢差异调控自然杀伤细胞功能。
Nat Metab. 2025 Aug 14. doi: 10.1038/s42255-025-01348-0.
2
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune Cells.一种用于免疫细胞多功能多重工程的独特碱基编辑平台。
bioRxiv. 2025 Jul 16:2025.07.11.664404. doi: 10.1101/2025.07.11.664404.
3
A side-by-side comparison of variant function measurements using deep mutational scanning and base editing.使用深度突变扫描和碱基编辑对变异功能测量进行的并列比较。

本文引用的文献

1
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.内源性检查点调控 T 细胞新抗原反应性和对 PD-1 阻断的敏感性。
Med. 2022 Oct 14;3(10):682-704.e8. doi: 10.1016/j.medj.2022.07.008. Epub 2022 Aug 24.
2
Inference of CRISPR Edits from Sanger Trace Data.从 Sanger 测序数据推断 CRISPR 编辑。
CRISPR J. 2022 Feb;5(1):123-130. doi: 10.1089/crispr.2021.0113. Epub 2022 Feb 2.
3
Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.CRISPR-Cas9 编辑的早期人类胚胎中频繁的杂合性丢失。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf738.
4
Precisely defining disease variant effects in CRISPR-edited single cells.精确界定CRISPR编辑的单细胞中的疾病变体效应。
Nature. 2025 Jul 23. doi: 10.1038/s41586-025-09313-3.
5
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing.通过非病毒工程和高度多重碱基编辑提高CAR-NK细胞的精准度。
J Immunother Cancer. 2025 May 7;13(5):e009560. doi: 10.1136/jitc-2024-009560.
6
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cells.四重腺嘌呤碱基编辑的同种异体嵌合抗原受体T细胞优于CRISPR/Cas9核酸酶工程改造的T细胞。
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2427216122. doi: 10.1073/pnas.2427216122. Epub 2025 May 5.
7
QBEmax is a sequence-permuted and internally protected base editor.QBEmax是一种序列置换且内部受保护的碱基编辑器。
Nat Biotechnol. 2025 Apr 21. doi: 10.1038/s41587-025-02641-9.
8
Current trends in gene therapy to treat inherited disorders of the brain.治疗遗传性脑部疾病的基因治疗当前趋势。
Mol Ther. 2025 May 7;33(5):1988-2014. doi: 10.1016/j.ymthe.2025.03.057. Epub 2025 Apr 2.
9
base editing of Angptl3 via lipid nanoparticles to treat cardiovascular disease.通过脂质纳米颗粒对血管生成素样蛋白3进行碱基编辑以治疗心血管疾病。
Mol Ther Nucleic Acids. 2025 Feb 15;36(2):102486. doi: 10.1016/j.omtn.2025.102486. eCollection 2025 Jun 10.
10
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy.用于癌症治疗的灵敏单特异性和双特异性合成嵌合T细胞受体的设计。
Nat Cancer. 2025 Apr;6(4):647-665. doi: 10.1038/s43018-025-00927-0. Epub 2025 Mar 17.
Proc Natl Acad Sci U S A. 2021 Jun 1;118(22). doi: 10.1073/pnas.2004832117. Epub 2021 Apr 9.
4
Massively parallel assessment of human variants with base editor screens.基于碱基编辑器的高通量人类变异评估。
Cell. 2021 Feb 18;184(4):1064-1080.e20. doi: 10.1016/j.cell.2021.01.012.
5
Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning.从目标文库分析和机器学习角度看碱基编辑结果的决定因素。
Cell. 2020 Jul 23;182(2):463-480.e30. doi: 10.1016/j.cell.2020.05.037. Epub 2020 Jun 12.
6
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity.通过噬菌体辅助进化提高 Cas 结构域兼容性和活性的腺嘌呤碱基编辑器。
Nat Biotechnol. 2020 Jul;38(7):883-891. doi: 10.1038/s41587-020-0453-z. Epub 2020 Mar 16.
7
Therapeutic base editing of human hematopoietic stem cells.人造血干细胞的治疗性碱基编辑。
Nat Med. 2020 Apr;26(4):535-541. doi: 10.1038/s41591-020-0790-y. Epub 2020 Mar 16.
8
Directed evolution of adenine base editors with increased activity and therapeutic application.通过定向进化提高腺嘌呤碱基编辑器的活性和治疗应用。
Nat Biotechnol. 2020 Jul;38(7):892-900. doi: 10.1038/s41587-020-0491-6. Epub 2020 Apr 13.
9
CRISPR-engineered T cells in patients with refractory cancer.经 CRISPR 基因编辑的 T 细胞治疗难治性癌症的患者。
Science. 2020 Feb 28;367(6481). doi: 10.1126/science.aba7365. Epub 2020 Feb 6.
10
'Off-the-shelf' allogeneic CAR T cells: development and challenges.现成的异体嵌合抗原受体 T 细胞:开发与挑战。
Nat Rev Drug Discov. 2020 Mar;19(3):185-199. doi: 10.1038/s41573-019-0051-2. Epub 2020 Jan 3.